BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14995001)

  • 21. Antibodies against free radical modified native DNA recognize B-conformation.
    Ara J; Ali A; Ali R
    Immunol Invest; 1992 Oct; 21(6):553-63. PubMed ID: 1330902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycated-H2A histone is better bound by serum anti-DNA autoantibodies in SLE patients: glycated-histones as likely trigger for SLE?
    Alam S; Arif Z; Alam K
    Autoimmunity; 2015 Feb; 48(1):19-28. PubMed ID: 25065453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity of antibodies to bacterial DNA in the sera of healthy human subjects and patients with systemic lupus erythematosus.
    Pisetsky D; Drayton D; Wu ZQ
    J Rheumatol; 1999 Sep; 26(9):1934-8. PubMed ID: 10493672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SLE anti-DNA autoantibodies binding estradiol-albumin-DNA conjugate.
    Moinuddin ; Ali A
    Lupus; 1994 Feb; 3(1):43-6. PubMed ID: 8025585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot].
    Ghedira I; Landolsi H; Mankai A; Fabien N; Jeddi M
    Pathol Biol (Paris); 2006 Apr; 54(3):148-54. PubMed ID: 16169158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antigen binding diversity of affinity purified autoantibodies against DNA.
    Ali A; Hasan R; Ali R
    Biochem Int; 1991 Jan; 23(1):111-8. PubMed ID: 1863265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies.
    Rasheed Z; Ahmad R; Rasheed N; Ali R
    Autoimmunity; 2007 Nov; 40(7):512-20. PubMed ID: 17966041
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
    Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
    Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naturally occurring anti-native DNA antibodies in SLE binding Z-DNA.
    Sehgal V; Ali R
    Indian J Med Res; 1990 Jun; 92():158-62. PubMed ID: 2401535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polynucleotide specificity of anti-reactive oxygen species (ROS) DNA antibodies.
    Ara J; Ali R
    Clin Exp Immunol; 1993 Oct; 94(1):134-9. PubMed ID: 8403495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA sequence and conformation specificity of lupus autoantibodies. Preferential binding to the left-handed Z-DNA form of synthetic polynucleotides.
    Thomas TJ; Meryhew NL; Messner RP
    Arthritis Rheum; 1988 Mar; 31(3):367-77. PubMed ID: 3358800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotoxic effect and antigen binding characteristics of SLE auto-antibodies to peroxynitrite-modified human DNA.
    Khan MA; Alam K; Mehdi SH; Rizvi MMA
    Arch Biochem Biophys; 2017 Dec; 635():8-16. PubMed ID: 29051068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of naturally occurring anti-DNA antibodies to estradiol.
    Moinuddin ; Ali A
    Biochem Mol Biol Int; 1998 Jul; 45(3):511-8. PubMed ID: 9679651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SLE autoantibodies are well recognized by peroxynitrite-modified-HSA: Its implications in the pathogenesis of SLE.
    Arif Z; Neelofar K; Tarannum A; Arfat MY; Ahmad S; Zaman A; Khan MA; Badar A; Islam SN; Iqubal MA
    Int J Biol Macromol; 2018 Jan; 106():1240-1249. PubMed ID: 28851636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of peroxynitrite-modified H2A histone in the induction and progression of rheumatoid arthritis.
    Khan MA; Dixit K; Uddin M; Malik A; Alam K
    Scand J Rheumatol; 2012; 41(6):426-33. PubMed ID: 22985259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
    Sjoholm AG; Martensson U; Sturfelt G
    J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a major linear C1q epitope allows detection of systemic lupus erythematosus anti-C1q antibodies by a specific peptide-based enzyme-linked immunosorbent assay.
    Vanhecke D; Roumenina LT; Wan H; Osthoff M; Schaller M; Trendelenburg M
    Arthritis Rheum; 2012 Nov; 64(11):3706-14. PubMed ID: 22740328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydroxyl radical modification of polyguanylic acid: role of modified guanine in circulating SLE anti-DNA autoantibodies.
    Garg DK; Moinuddin ; Ali R
    Immunol Invest; 2003 Aug; 32(3):187-99. PubMed ID: 12916708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preferential recognition of methylglyoxal-modified calf thymus DNA by circulating antibodies in cancer patients.
    Ahmad MI; Ahmad S; Moinuddin
    Indian J Biochem Biophys; 2011 Aug; 48(4):290-6. PubMed ID: 22053699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.